143 related articles for article (PubMed ID: 24872145)
1. Resveratrol attenuates bone cancer pain through the inhibition of spinal glial activation and CX3CR1 upregulation.
Cheng W; Zhao Y; Liu H; Fan Q; Lu FF; Li J; Yin Q; Yan CD
Fundam Clin Pharmacol; 2014 Dec; 28(6):661-70. PubMed ID: 24872145
[TBL] [Abstract][Full Text] [Related]
2. Involvement of CX3CR1 in bone cancer pain through the activation of microglia p38 MAPK pathway in the spinal cord.
Hu JH; Yang JP; Liu L; Li CF; Wang LN; Ji FH; Cheng H
Brain Res; 2012 Jul; 1465():1-9. PubMed ID: 22613229
[TBL] [Abstract][Full Text] [Related]
3. The analgesic effects of triptolide in the bone cancer pain rats via inhibiting the upregulation of HDACs in spinal glial cells.
Hu XF; He XT; Zhou KX; Zhang C; Zhao WJ; Zhang T; Li JL; Deng JP; Dong YL
J Neuroinflammation; 2017 Nov; 14(1):213. PubMed ID: 29096654
[TBL] [Abstract][Full Text] [Related]
4. New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis.
Sun S; Cao H; Han M; Li TT; Pan HL; Zhao ZQ; Zhang YQ
Pain; 2007 May; 129(1-2):64-75. PubMed ID: 17123734
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal injection of anti-CX3CR1 neutralizing antibody delayed and attenuated pain facilitation in rat tibial bone cancer pain model.
Yin Q; Cheng W; Cheng MY; Fan SZ; Shen W
Behav Pharmacol; 2010 Oct; 21(7):595-601. PubMed ID: 20736819
[TBL] [Abstract][Full Text] [Related]
6. CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats.
Hu XM; Liu YN; Zhang HL; Cao SB; Zhang T; Chen LP; Shen W
J Neurochem; 2015 Feb; 132(4):452-63. PubMed ID: 25393328
[TBL] [Abstract][Full Text] [Related]
7. Suppression of histone deacetylases by SAHA relieves bone cancer pain in rats via inhibiting activation of glial cells in spinal dorsal horn and dorsal root ganglia.
He XT; Hu XF; Zhu C; Zhou KX; Zhao WJ; Zhang C; Han X; Wu CL; Wei YY; Wang W; Deng JP; Chen FM; Gu ZX; Dong YL
J Neuroinflammation; 2020 Apr; 17(1):125. PubMed ID: 32321538
[TBL] [Abstract][Full Text] [Related]
8. The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain.
Guo CH; Bai L; Wu HH; Yang J; Cai GH; Wang X; Wu SX; Ma W
Int J Mol Med; 2016 Nov; 38(5):1433-1442. PubMed ID: 28025994
[TBL] [Abstract][Full Text] [Related]
9. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats.
Milligan ED; Zapata V; Chacur M; Schoeniger D; Biedenkapp J; O'Connor KA; Verge GM; Chapman G; Green P; Foster AC; Naeve GS; Maier SF; Watkins LR
Eur J Neurosci; 2004 Nov; 20(9):2294-302. PubMed ID: 15525271
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model.
Ren BX; Gu XP; Zheng YG; Liu CL; Wang D; Sun YE; Ma ZL
Anesthesiology; 2012 Jan; 116(1):122-32. PubMed ID: 22123524
[TBL] [Abstract][Full Text] [Related]
11. Evidence for involvement of spinal RANTES in the antinociceptive effects of triptolide, a diterpene triepoxide, in a rat model of bone cancer pain.
Hang LH; Li SN; Shao DH; Chen Z; Chen YF; Shu WW
Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):477-80. PubMed ID: 24810483
[TBL] [Abstract][Full Text] [Related]
12. Antiallodynic effects of propentofylline Elicited by interrupting spinal glial function in a rat model of bone cancer pain.
Yao M; Chang XY; Chu YX; Yang JP; Wang LN; Cao HQ; Liu MJ; Xu QN
J Neurosci Res; 2011 Nov; 89(11):1877-86. PubMed ID: 21812015
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord.
Lu C; Liu Y; Sun B; Sun Y; Hou B; Zhang Y; Ma Z; Gu X
Inflammation; 2015 Oct; 38(5):1880-90. PubMed ID: 25896633
[TBL] [Abstract][Full Text] [Related]
14. An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine.
Milligan E; Zapata V; Schoeniger D; Chacur M; Green P; Poole S; Martin D; Maier SF; Watkins LR
Eur J Neurosci; 2005 Dec; 22(11):2775-82. PubMed ID: 16324111
[TBL] [Abstract][Full Text] [Related]
15. Regulation of spinal neuroimmune responses by prolonged morphine treatment in a rat model of cancer induced bone pain.
Cao F; Gao F; Xu AJ; Chen ZJ; Chen SS; Yang H; Yu HH; Mei W; Liu XJ; Xiao XP; Yang SB; Tian XB; Wang XR; Tian YK
Brain Res; 2010 Apr; 1326():162-73. PubMed ID: 20176002
[TBL] [Abstract][Full Text] [Related]
16. Minocycline attenuates bone cancer pain in rats by inhibiting NF-κB in spinal astrocytes.
Song ZP; Xiong BR; Guan XH; Cao F; Manyande A; Zhou YQ; Zheng H; Tian YK
Acta Pharmacol Sin; 2016 Jun; 37(6):753-62. PubMed ID: 27157092
[TBL] [Abstract][Full Text] [Related]
17. XPro1595 ameliorates bone cancer pain in rats via inhibiting p38-mediated glial cell activation and neuroinflammation in the spinal dorsal horn.
Zhou KX; He XT; Hu XF; Zhao WJ; Li CX; Zhang C; Zhang T; Gu ZX; Deng JP; Dong YL
Brain Res Bull; 2019 Jul; 149():137-147. PubMed ID: 31002915
[TBL] [Abstract][Full Text] [Related]
18. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia.
Zhang RX; Liu B; Wang L; Ren K; Qiao JT; Berman BM; Lao L
Pain; 2005 Nov; 118(1-2):125-36. PubMed ID: 16154703
[TBL] [Abstract][Full Text] [Related]
19. Involvement of spinal CC chemokine ligand 5 in the development of bone cancer pain in rats.
Hang LH; Shao DH; Chen Z; Chen YF; Shu WW; Zhao ZG
Basic Clin Pharmacol Toxicol; 2013 Nov; 113(5):325-8. PubMed ID: 23773283
[TBL] [Abstract][Full Text] [Related]
20. Extracellular signal-regulated kinase activation in spinal astrocytes and microglia contributes to cancer-induced bone pain in rats.
Wang XW; Li TT; Zhao J; Mao-Ying QL; Zhang H; Hu S; Li Q; Mi WL; Wu GC; Zhang YQ; Wang YQ
Neuroscience; 2012 Aug; 217():172-81. PubMed ID: 22564552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
